Orit Geva-Dvash - 17 Aug 2026 Form 4 Insider Report for CAMTEK LTD (CAMT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
18 Aug 2026, 07:39:18 UTC
Prior SEC filing
13 Aug 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact

Key filing fact

Orit Geva-Dvash filed Form 4 for CAMTEK LTD (CAMT) on 18 Aug 2026.

Key facts

  • This page summarizes Orit Geva-Dvash's Form 4 filing for CAMTEK LTD (CAMT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Aug 2026, 07:39.

Change

  • Previous filing in this sequence was filed on 13 Aug 2026.
  • Current net transaction value: -$88,900.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001973444 Primary reporting owner

Geva-Dvash Orit

Relationship
Vice President, HR
Address
EXODUS 6, ZICHRON YAAKOV, ISRAEL
Signature
/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact
Signature date
18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CAMT transaction

Ordinary Shares

Sale

Transaction value
$88,900
Shares
-508
Change %
-8.9%
Price
$175.00
Shares after
5,205
Date
17 Aug 2026
Ownership
Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .